谷歌浏览器插件
订阅小程序
在清言上使用

Why Was There Ever a Warning Not to Use Cephalosporins in the Setting of a Penicillin “Allergy”?

Journal of allergy and clinical immunology In practice/˜The œJournal of allergy and clinical immunology In practice(2021)

引用 7|浏览7
暂无评分
摘要
It is now well-established that avoiding beta-lactam antibiotics, when they are the drugs of choice, results in significantly worse long-term global outcomes for patients. Much of this avoidable morbidity has been caused by widespread warnings in electronic health care record systems not to use cephalosporins in the setting of penicillin allergy. High rates, up to 1000-fold higher than now seen, of immunologically mediated reactions were associated with early impure penicillin preparations. This instilled a rational fear of beta-lactameassociated anaphylaxis in generations of physicians. In the late 1970s, several editorial comments regarding a potential increased risk to patients given cephalosporins who had a history of a penicillin allergy resulted in the warning that became imbedded in the culture of medicine. Over the past 40 years, compelling data have been developed that refute this warning and showed that the risks of avoiding cephalosporins outweighed the benefits. In late 2017, Kaiser Permanente Southern California completely removed all warnings not to use cephalosporins in the setting of a penicillin allergy. The results have recently been published in JAMA Network Open. This Rostrum article provides some of the backstory on the establishment and removal of this warning for physicians who trained over the past 30 years. (C) 2021 American Academy of Allergy, Asthma & Immunology.
更多
查看译文
关键词
Allergy,Anaphylaxis,Cephalosporin,Co-sensitization,Cross-reactivity,Hypersensitivity,Penicillin,Warning
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要